Extracorporeal membrane oxygenation (ECMO) refers to specific mechanical devices used
to temporarily support the failing heart and/or lung. Technological advances as well as …

To determine whether inhibition of either the ribosomal p70 S6 kinase or eukaryotic initiation
factor (eIF) 4E pathways downstream of the mammalian target of rapamycin, mTOR …

EXTRACORPOREAL MEMBRANE oxygenation (ECMO) was first used in the perioperative
care of a lung transplantation patient in 1975, a mere 3 years after initial introduction into …

END-STAGE LUNG DISEASE represents respiratory failure resulting from myriad etiologies
and is one of the leading causes of death in the developed world. 1 Although medical …

It is thought that G1 cyclin/CDK mediated phosphorylation of pocket proteins from mid G1 to
mitosis is reversed via dephosphorylation in mitosis. We examined the mechanisms …

This article spotlights the research highlights of this year that specifically pertain to the
specialty of anesthesia for heart transplantation. This includes the research on recent …

END-STAGE HEART FAILURE (HF) results from a myriad of etiologies and represents a
major financial and healthcare burden. 1 Since 1983, nearly 150,000 pediatric and adult …

This special article is the fourteenth in an annual series for the Journal of Cardiothoracic and
Vascular Anesthesia. The authors thank the Editor-in-Chief, Dr. Kaplan, and the editorial …

THIS SPECIAL article is the 13th in an annual series for the Journal of Cardiothoracic and
Vascular Anesthesia. The authors thank the editor-in-chief, Dr Kaplan, and the editorial …

CORONARY ARTERY DISEASE (CAD) is the leading cause of mortality over much of the
globe, with over 7 million deaths worldwide attributed to CAD annually. 1 The disease …